Zoledronic acid (Reclast/Zometa)

zoledronic acid · Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zoledronic acid (Reclast/Zometa), covering 2024-05-14 to 2024-05-14. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation